Sun Pharma Advanced Research Company informs about press release

03 Dec 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed a Press Release on December 03, 2021 titled ‘SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target’.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

124.65 -4.70 (-3.63%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 542.55
Indegene 474.00
CMS Info Systems 319.15
Sagility 51.76
Smartworks Coworking 438.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×